In our sample, APOE4 carriers consistently had worse performance on the dementia screener (MoCA) and the episodic memory domain scores across analyses, which is consistent with the body of evidence tying APOE4 genotype to Alzheimer’s pathological processes and patterns of cognitive performance that are consistent with memory declines (El Haj et al., 2016). The gene discussed is APOE; the disease is dementia.